About this sample
This is an illustrative sample using biologics development and manufacturing as the example category, chosen because it spans both development and manufacturing capability — a combination AI models often struggle to represent together accurately.
Why this category is instructive
Buyers evaluating biologics CDMOs typically ask about specific modalities, cell line development, and scale — from process development through commercial-scale manufacturing. Demonstrating this category shows how AI handles organisations whose offering spans multiple, distinct stages of work.
Illustrative finding pattern
In our demonstration sampling, AI responses to biologics CDMO prompts frequently emphasised manufacturing scale while underrepresenting early-stage development capability, or vice versa, unless an organisation's public materials described both halves of its offering with equal specificity.
What the full report includes
A completed report for a biologics CDMO client documents how AI currently represents both development and manufacturing capability, where the two are blurred or missing, and the specific changes required so AI can describe the full, integrated offering accurately.